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The IO is a unique structure composed of cells with a very low discharge rate of 1-3 spikes/s (Lang 2002; Montarolo et al. 1982) and it exhibits somatotopic organization (Gellman et al. 1983; Van Ham and Yeo 1992) . Relevant to eyeblink conditioning, the medio-rostral parts of the dorsal accessory olive and the dorsal lamella of the principal olive receive somatosensory inputs from the contralateral facial area (Weiss et al. 1993) . Being the sole source of climbing fibers projecting to the cerebellum, the IO has a strong influence on cerebellar activity (Batini and Billard 1984; Montarolo et al. 1982; Zbarska et al. 2007 ). As such it plays a pivotal role in modern concepts of cerebellum-dependent motor learning.
One of the most investigated concepts is the cerebellar learning hypothesis first proposed by Marr (1969) and Albus (1971) . This hypothesis, when adapted to eyeblink conditioning, proposes that conditioned stimulus (CS) sensory information is supplied to the cerebellum by mossy fibers and that climbing fibers encode unconditioned stimulus (US) information. It is thought that coactivation of mossy fiber CS and climbing fiber US inputs leads to plastic changes that increase the responsiveness of Purkinje and cerebellar nuclear cells to the CS, resulting in the production of CR motor commands (Attwell et al. 2001; Mostofi et al. 2010; Thompson et al. 1997; Thompson and Steinmetz 2009) . In this context, the US sensory information is mediated by the IO and the US-locked discharge of climbing fibers is considered to have an essential reinforcing or teaching role (Mauk et al. 1986; Steinmetz et al. 1989) . The cerebellar learning hypothesis predicts that blocking the IO-mediated US signals to the cerebellum should lead to the extinction of previously acquired CRs (McCormick et al. 1985; Medina et al. 2002) .
Although seemingly straightforward, testing this prediction turned out to be challenging. The problem is that besides carrying sensory signals to the cerebellum, the IO also regulates the tonic activity of cerebellar networks (Batini et al. 1985; Benedetti et al. 1983; Lang 2002; Montarolo et al. 1982) . For example, it has been proposed that the putative function of IO sensory signals could be tested by blocking glutamatemediated sensory signals in the IO (Medina et al. 2002; Zbarska et al. 2008) . However, we found that this treatment not only abolishes previously learned CRs, but it also dramatically suppresses neuronal activity in cerebellar interposed nuclei (Zbarska et al. 2007 (Zbarska et al. , 2008 . This undesirable tonic side effect rendered the cerebellum dysfunctional and obscured the behavioral outcome of the experiment. It became clear that future tests of the IO's function in eyeblink conditioning will require new approaches that would block IO sensory signals while exerting minimal effects on spontaneous firing of the IO.
It is known that IO sensory signals are glutamate mediated and that injections of fast glutamate receptor antagonists, such as 1,2,3,4-tetrahydro-6-nitro-2,3-dioxo-benzo(f)quinoxaline-7-sulfonamide (NBQX), block these responses and also suppress IO spontaneous firing (Lang 2002) . On the other hand, it has been shown in anesthetized rats that blocking inhibitory inputs to the IO with picrotoxin increased tonic activity of IO neurons (Lang 2002) . Importantly, combined injections of NBQX and picrotoxin blocked IO responses to the motor cortex stimulation but had a smaller effect on IO spontaneous firing compared with injections of NBQX alone (Lang 2002) . Based on these electrophysiological experiments, we hypothesized that combined injections of glutamate and GABA antagonists could be effective in blocking IO US inputs while minimizing changes in IO and cerebellar tonic activity.
To address this issue, we designed experiments where welltrained rabbits were injected into the dorsal accessory IO (DAO) first with the glutamate receptor blocker ␥-D-glutamylglycine (DGG) and then with the GABA A receptor antagonist gabazine. Based on our previous studies, we expected DGG to abolish CRs by suppressing first the IO and then interposed nuclei (IN) neuronal firing (Zbarska et al. 2007 ). We speculated that if DGG suppressed CRs mainly via its tonic effects on cerebellar circuits, then subsequent injections of gabazine should boost the suppressed IO spontaneous firing, improve the functional state of cerebellar circuits, and restore behavioral CRs. On the other hand, if the mechanism of the DGG effect includes extinction of CRs due to the absence of US signals, then restoring IO spontaneous firing to the normal, pre-DGG level should not restore behavioral CRs. In the first part of these experiments, we tested the singular effects of DGG and gabazine on CR performance when injected during separate training sessions. We found that while DGG abolished CRs, gabazine preserved them with shortened CR onset latencies. In the second part of this study, DGG and gabazine were injected into the IO sequentially during the same training session. We found that after DGG abolished CRs, gabazine triggered a relatively fast CR recovery. These findings suggest that the level of IO neuronal activity is critical for the performance of CRs. Furthermore, combining glutamate and GABA A blockers for suppressing the IO's task-related signals while maintaining its activity at near normal levels represents a highly promising approach for uncovering the IO function.
METHODS

Subjects.
The study was performed in seven male New Zealand white rabbits (Harlan, Indianapolis, IN), weighing 2.5-3.0 kg and being 3-to 4-mo old at the beginning of experiments. First, the effect of gabazine in the IO on CR expression was examined in a group of five rabbits. In the second set of experiments, these five rabbits were planned to be used to test the effect of sequentially combined injections of DGG and gabazine in the IO on CR performance. However, in two animals drug effects had degraded across days due to excessive injection-site gliosis; therefore, they were replaced by two new subjects (second group n ϭ 5). Rabbits were housed individually on a 12:12-h light-dark cycle and provided with food and water ad libitum. All experiments were performed in accordance with the National Institutes of Health' Surgery. Aseptic surgical procedures were performed on naive rabbits anesthetized with a mixture of ketamine (50 mg/kg), xylazine (6 mg/kg), and acepromazine (1.5 mg/kg). During surgery, lambda was positioned 1.5 mm below bregma. Three stainless steel anchor screws were secured to the exposed skull, and a 27-gauge injection guide tube was implanted to target the anterior dorsal parts of the right IO using the following stereotaxic coordinates (relative to lambda): anteroposterior ϭ x Ϫ (0.69x ϩ 4.5) mm, where x is the horizontal distance (in mm) between bregma and lambda; mediolateral ϭ 1.0 mm and dorso-ventral ϭ 22.4 mm. The implant and a small Delrin platform were then affixed to the skull anchor screws with dental cement. Following surgery, the injection guide tube was protected by a removable cap. During experiments, the Delrin platform held an aluminum stage designed to accommodate the air-puff delivery tube and the infrared eyeblink sensor. All animals were treated with antibiotics for 1 wk postsurgery. Between experiments, the patency of the injection guide tube was protected by a 33-gauge stainless steel stylet.
Training procedures. One week after surgery, all rabbits were first adapted to a restraint box in a sound-attenuated experiment chamber for 3 days, 30 min per day. Head movements were not restricted. Adapted animals were conditioned in the standard delay classical conditioning paradigm until they reached 90% of CRs for 3 consecutive days. The CS was an 85-db, 450-ms, 1-kHz tone, superimposed on a continuous 70-db white noise background. The CS coterminated with a 100-ms airpuff US (37 psi at the source) applied to the left eye. The interstimulus interval was 350 ms, and each daily training session consisted of 100 trials presented at pseudorandomized intertrial intervals of 15-25 s.
Injection procedures. Before each injection experiment, a 33-gauge stainless steel injection needle was connected to a 10-l Hamilton syringe using transparent Tygon tubing. The tubing was first filled with ultra-purified water, and then a small bubble was drawn into the end of the injection needle before drawing in drug. The bubble was used for monitoring the injected volume relative to gradation marks on the transparent tubing. The injection needle was inserted in the implanted guide tube before beginning the experiment. At the beginning of every injection session, 40 trials of paired stimuli were delivered to assure that needle insertion had no effect on CR performance and to assess baseline eyeblink performance. Intracranial microinjections were performed manually at a rate of 0.5 l/min. All drugs were dissolved in artificial cerebrospinal fluid (aCSF), and their pH was adjusted to 7.4 Ϯ 0.1.
Single drug injection procedures. The present study had two objectives. In the first group of rabbits (n ϭ 5), the effect of the GABA A receptor antagonist gabazine (Ascent Scientific, Westonsuper-Mare, UK) on CR performance was examined. Before gabazine was tested, the effective depth for injections was determined by finding sites where DGG abolished CRs. During this mapping stage, 1.0 l of DGG (Tocris Bioscience; 100 mM) was first injected at the depth of the guide tube tip. If CR abolition was not observed, the drug was injected 0.5 mm deeper the next day. Once the effective injection site was determined, an injection of 1.0 l of gabazine (1 M) was performed at the same depth in the next experimental session. Each session consisted of 40 preinjection and 110 postinjection paired trials, which were administered immediately following the injection. If no effect on CR performance was observed, then the gabazine concentration was increased to 2 M for the next daily session. During control experiments, a corresponding volume of vehicle (aCSF), equal to that in gabazine experiments, was administered into the IO.
Combined drug injection procedures. The second objective of this study (n ϭ 5) was to test whether CRs abolished by blocking olivary excitatory inputs could be restored by reducing GABA-mediated inhibition in the IO. Similar to single-drug experiments, after 40 preinjection trials, rabbits were injected with 1 l of DGG. In four rabbits, complete CR abolition occurred within the first 20 post-DGG trials. One rabbit required an additional 1 l of DGG, administered after the 20th postinjection trial, to achieve complete CR abolition. After CRs were abolished for Ն20 consecutive trials, the presentation of paired trials was paused at trial 80 (40th postinjection trial), and the injection needle was removed, cleaned, and refilled with gabazine. On average, the refilling process took about 3 min. Then, 1.0 l of gabazine (2 M) was injected at the same depth where DGG had been administered previously. In the rabbit who received two sequential DGG injections, one additional 1.0-l injection of gabazine was administered 20 trials (trial 100) after the first gabazine injection. Overall, combined injection experiments consisted of 180 trials (40 pre-DGG trials, 40 post-DGG/pregabazine trials, and 100 postgabazine trials). During control experiments, the same group of rabbits was first injected with the corresponding volume of DGG, and then after complete CR abolition, the vehicle aCSF was administered into the IO according to the schedule established for gabazine.
Data recording and analysis. The eyeblinks were recorded using a head-mounted infrared sensor that measures infrared light reflected from the eye and peri-orbital region (Ryan et al. 2006) . The output of the sensor was amplified, digitized at 1 kHz with 12-bit resolution, and displayed and stored on a custom data acquisition system. During each trial, data were acquired for 1,400 ms, beginning with 250 ms of baseline before the CS onset and extending for 800 ms beyond the US onset. Eyeblink responses in the time frame 25 ms after CS onset and before US onset were considered CRs when they exceeded the mean of the signal in the 250-ms baseline period by more than five SDs (ϳ0.1 mm change in the eye aperture). This relatively low threshold was selected to capture small responses that could be present during an incomplete drug effect or when the drug effect starts to recover. Any blink exceeding the CR threshold within 25 ms after CS onset was classified as an alpha response. Trials containing spontaneous blinks or rare alpha responses were stored but were not included in data analyses.
Eyeblink responses from each trial were examined offline. Means for CR incidence, baseline eyelid aperture, and response latency were calculated and plotted for consecutive blocks of 10 trials. Baseline eyeblink aperture was determined as average eyelid aperture during the initial 250 ms preceding the CS for each trial. Baseline eyelid apertures were normalized by expressing them as a percentage of full eyeblink amplitude in each particular rabbit. The full eyeblink amplitude was determined as the difference between the lowest (corresponds to completely open eyelids) and highest (eyelids completely closed) signal levels in each experimental session.
In addition to the visualization of eyeblink traces on the computer monitor, two video cameras were installed in the experiment chamber to monitor general animal behavior during experiments. One camera provided a front view of the rabbit's head, and the other one was positioned on the side of the trained eye. This setup proved to be invaluable for determining the correct position of the eyeblink sensor and for detecting drug injection side effects.
For the statistical analysis, we used two-way repeated-measures ANOVA with the following factors: rabbit and drug (3 levels: DGG, gabazine, and aCSF). The repeated factor was the 10-trial block comprising each phase of an experiment (before and after injection). For the analysis of experiments from the second group of rabbits with double injections, the ANOVA included an additional time/dose level (after DGG injection and after gabazine injection) to account for different effects of these two drugs during one experiment. We generated planned contrasts from the ANOVAs to address hypotheses regarding patterns of CR incidence and latencies and baseline eyelid aperture arising from the interaction between treatments and phases of experiment. Specifically, using groups of 10-trial blocks, we performed 1-df contrasts of the difference between preinjection and postinjection blocks within and between experiments with drug and vehicle injections. All group data are reported as means Ϯ SE. The Fig. 1 . Location of injection sites in the inferior olive (IO). In first group of rabbits (૽ and ; n ϭ 5), the effect of gabazine in the IO on conditioned response (CR) expression was examined. Three out of this first group (૽ ) and an additional 2 rabbits (OE) formed the second experimental group (n ϭ 5). This group was used to test the effect of sequentially combined injections of ␥-D-glutamylglycine (DGG) and gabazine in the IO on CR performance. A-F: reconstructed sites in individual animals were transferred to a set of standardized coronal sections of the rabbit medulla, arranged in rostral-tocaudal order. Anterior-posterior distance in mm from the rostral pole of the IO is at bottom right. All injection sites were found within or close to the rostral part of the IO complex. Injections of DGG at all marked sites abolished CR expression. G: an example microphotograph of a stained coronal section (corresponding to section D) showing the DAO injection site in the rabbit whose data are presented as an individual example in Fig. 4 . Because the tissue was sectioned parallel to the stereotaxic vertical, a large part of the track formed by the implanted injection guide tube through the medulla is seen. Arrow points to the injection site identified by the deepest deposit of black tissue-marking dye. Most of the dye, which has limited solubility in water, spread upward and fills the lumen of the guide tube track. Injection site is surrounded by a narrow gliotic area (dense grey) which extends slightly below the dorsal accessory inferior olive (DAO). The gliotic scar typically forms as a consequence of multiple penetrations of the tissue by the injection needle. IOM, medial inferior olive; IOPr, principal inferior olive; Sp5N, spinal trigeminal nucleus; sp5, spinal trigeminal tract; Pr, prepositus hypoglossal nucleus; 7N, facial nucleus; icp, inferior cerebellar peduncle; MVe, medial vestibular nucleus; SolN, solitary nucleus; Amb, ambiguous nucleus; DCN, dorsal cochlear nucleus. level of statistical significance was set at P Ͻ 0.05. All statistical analyses were performed using Statsoft's Statistica.
Histology. After all experiments were completed, rabbits were deeply anesthetized with a cocktail of ketamine (100 mg/kg), xylazine (12 mg/kg), and acepromazine (3 mg/kg). The injection site was marked by injecting 1 l of tissue-marking dye. Anesthetized animals were transcardially perfused with 1 liter of PBS followed by 1 liter of a tissue fixative (10% buffered formalin). Brains were carefully removed and placed in a solution of 30% sucrose and 10% formalin. After Ն1 wk, brains were sectioned coronally at 50 m on a freezing microtome. Sections were mounted onto gelatin-coated slides, dried, and stained with Luxol blue and neutral red. Locations of injection sites were determined using bright field microscopy and transferred to a standardized set of coronal sections of the rabbit medulla.
RESULTS
Location of injection sites and general observations. Seven rabbits were implanted with an injection cannula in the IO. The histological analysis of IO injection sites revealed that they all were located in the rostral portion of the IO complex, close to the dorsal accessory IO (Fig. 1) . All rabbits reached the 90% CR criterion in 6 -15 sessions. After rabbits were well trained, effective injection sites were established by microinjecting the IO with DGG. Similar to our previously reported results, DGG injections in the IO abolished CR expression and increased tonic eyelid aperture. In the first experiment phase following injection-site mapping, injections of gabazine at the same sites shortened CR latencies and increased tonic eyelid closure. Besides these effects on eyelid movements, gabazine injections also affected posture. In most experiments, rabbits exhibited counterclockwise torticollis with the left eye pointing upward, while the forelimbs were extended to the opposite side. After gabazine injections, several rabbits developed wheezy breathing together with excessive nasal production of mucus. All of these side effects dissipated within a couple of hours postinjection.
Effect of gabazine on CR expression. To find effective infusion sites, the IO was first microinjected with the AMPA/ kainate and NMDA receptor blocker DGG. As previously described by Zbarska et al. (2007) , DGG abolished CRs at the most effective injection sites ( Fig. 2A) . During the 40 preinjection trials, trained rabbits exhibited high CR incidence. CRs were gradually abolished shortly after DGG injections ( Fig.  2A) . As shown in the example illustrated in Fig. 2A , DGG frequently also reduced UR amplitude in paired CS/US trials. Injections of the vehicle at the same sites had no effect on CR performance (Fig. 2C) .
The onset of DGG-induced CR abolition varied from 3 to 15 min between rabbits. Group data (n ϭ 5) revealed that CR incidence gradually decreased from 74 Ϯ 14% in the first postinjection block of 10 trials to 4 Ϯ 2.5% in the fifth postinjection block (Fig. 3A) . CRs remained abolished for Ն60 trials. During the last two blocks of trials, partial recovery began in two out of five rabbits, and on average, CR incidence in the last block was 14 Ϯ 8.7% (Fig. 3A) . Contrast analysis from the repeated-measures ANOVA revealed a significant effect of DGG [F(1,4) ϭ 284.4; P Ͻ 0.001] when comparing preinjection performance with CR incidence in all postinjection blocks. DGG injections produced a discernible, but statistically insignificant, tonic eyelid opening (Fig. 3C) .
To examine the effects of elevating IO activity via blocking GABA neurotransmission, microinjections of the GABA A receptor antagonist gabazine were administered at the same injection sites as DGG. Gabazine shortened CR latencies, without affecting CR incidence (Fig. 2B) , and increased tonic eyelid closure. Across all animals, CR incidence during the first, fifth, and last blocks of postinjection trials were 98 Ϯ 2, 98 Ϯ 2, and 96 Ϯ 2.5%, respectively (Fig. 3A) . In contrast, gabazine affected CR latency immediately after its application. The CR latency dropped from 155.8 Ϯ 14.1 ms during the last preinjection block to 122.5 Ϯ 14.3, 108.9 Ϯ 11.4, and 115.1 Ϯ 8.7 ms during the first, fifth and last blocks of postinjection trials, respectively (Fig. 3B ). This decrease was significant when comparing CR latencies of all preinjection and all postinjection blocks [F(1,4) ϭ 10.1; P ϭ 0.034]. CR latencies following gabazine injections were also significantly shorter compared with the corresponding time window in control vehicle injection experiments [F(1,4) ϭ 10.2; P ϭ 0.033]. At the group level, gabazine also had an effect on tonic eyelid closure. It doubled from 13.7 Ϯ 4.0% during the last preinjection block of trials to 27.8 Ϯ 10.3% during the first postinjection block of trials, and continued increasing to 51.9 Ϯ 15.5 and 53.4 Ϯ 15.5% during the fifth and the last postinjection blocks, respectively (Fig. 3C) . The repeated-measures ANOVA indicated significant effects of gabazine on baseline eyelid aperture. Tonic eyelid closure was significantly greater after gabazine administration, both within drug experiments [F(1,4) ϭ 11.04; P Ͻ 0.029], as well as between drug and control experiments [F(1,8) ϭ 8.1; P ϭ 0.021]. Vehicle injections did not affect CR performance, latency or tonic baseline eyelid aperture (Fig. 3,  B and C) .
Combined effect of DGG and gabazine on CR performance. Combined DGG/gabazine injection experiments tested whether DGG-abolished CRs could be restored by elevating IO spontaneous activity with gabazine. As expected, injecting DGG in the IO abolished CRs (Fig. 4A) . At the group (n ϭ 5) level it reduced CRs from 98 Ϯ 2% during the last preinjection block of trials to 6 Ϯ 4% during the last block of trials before the gabazine injection (Fig. 5A) . The repeated-measures ANOVA yielded significant DGG effects on CR incidence when comparing preinjection performance to the four post-DGG blocks [F(1,4) ϭ 176.2; P Ͻ 0.001].
When gabazine was administered following four post-DGG blocks of trials, a gradual CR recovery was observed with variable delay (Fig. 4A) . Delays in recovery varied among rabbits from immediately to 16 min postgabazine. On average, following gabazine, CR incidence increased to 8 Ϯ 8% during the first postinjection block of trials and to 42 Ϯ 24 and 94 Ϯ 6% during the fifth and last blocks of postinjection trials, respectively (Fig. 5A ). This relatively fast postgabazine recovery contrasted with control experiments where the DGG injection was followed by vehicle administration. In most control experiments, CR recovery either did not occur at all or most recovered CRs appeared later or sporadically and had small Fig. 3 . Group effects of gabazine (ࡗ), DGG (□), and aCSF (OE) (means Ϯ SE; n ϭ 5). A: effect of drugs on CR incidence. While DGG suppressed CRs, gabazine and control injections of vehicle had no effect on CR incidence. B: effect of gabazine and vehicle on eyeblink latency. DGG abolished CRs and thus their latencies are not shown. Gabazine decreased the CR onset time. C: effect of drugs on baseline eyelid aperture expressed as a percentage of maximum eyelid aperture. Gabazine produced a gradual and long-lasting eyelid closure. Control injections of aCSF or DGG did not affect baseline eyelid aperture significantly, though the trend for DGG was increased eyelid aperture. amplitudes and low incidence (Fig. 4B) . Similar to the experimental group, DGG in controls abolished CRs [F(1,4) ϭ 179.2; P Ͻ 0.001; Fig. 5A ]. CR incidence dropped from 98 Ϯ 2% during the preinjection blocks of trials to 4 Ϯ 2.5% during the fourth post-DGG block of trials (Fig. 5A) . After vehicle administration, CRs remained abolished for Ն50 trials. Partial recovery occurred in two out of five rabbits during the last 50 trials. As a result, average CR incidence recovered to 26 Ϯ 9.3% during the 10th post-DGG block of trials and to 38 Ϯ 12% by the last block of trials (Fig. 5A) . The repeated-measures ANOVA yielded a significant gabazine effect on CR incidence when comparing postgabazine blocks with the postvehicle blocks from DGG-vehicle control experiments [F(1,8) ϭ 19.5; P ϭ 0.002] and also compared with the vehicle-vehicle control experiments [F(1,8) 19.9; P ϭ 0.002]. In this group of rabbits, two sequential injections of vehicle had no affect on CR incidence [ Fig. 5A; F(1,4) 
Latencies of gabazine-restored CRs were shorter on average than during pre-DGG trials. They decreased from 182.4 Ϯ 20.3 ms during the preinjection period to 149.2 Ϯ 24.1 ms during the last 50 trials, but this effect was not significant [F(1,4) ϭ 0.49; P ϭ 0.53].
The gabazine-induced CR recovery was accompanied by tonic eyelid closure, which increased from 3.6 Ϯ 0.6% during the first postgabazine block of trials to 32.9 Ϯ 8.7 and 29.6 Ϯ 7.1% during the last two blocks of trials (Fig. 5B) 
DISCUSSION
The data presented here demonstrate that 1) blocking fast glutamate receptors in the DAO abolishes previously learned CRs; 2) blocking GABA A receptors in the DAO shortens CR latencies and increases tonic eyelid closure without affecting CR incidence; and 3) the recovery of DGG-abolished CRs can be significantly accelerated by follow-up injections of gabazine.
IO and eyeblink conditioning circuits. Before considering possible neurophysiological mechanisms of our findings, the involvement of the IO in eyeblink conditioning circuits has to Fig. 4 . An example of the effects of combined DGG-gabazine and DGG-aCSF on CR expression. These 2 examples were recorded in 2 different sessions with the same animal. A: effects of sequential injections of DGG and gabazine into the IO on CR expression. Following gabazine, DGG-abolished CRs were restored after some delay. B: eyeblink records in an experiment where the IO was first injected with DGG followed by a control injection of aCSF. CRs did not recover after being abolished by the same amount of DGG that had been administered in the previous DGGgabazine experiment.
be addressed. First of all, eyeblink conditioning and the generation of eyeblink CRs critically depend on the intermediate cerebellum, which consists of the intermediate cerebellar cortex and IN Thompson and Steinmetz 2009; Yeo 1991) . The IN send projections to eyeblink premotoneurons (Fig. 6) . It is thought that in response to incoming sensory signals, IN participate in the formulation of a CR motor command (Thompson 1986 ). The main sources of task-related sensory signals to the intermediate cerebellum are pontine nuclei, which supply both CS (Steinmetz et al. 1989; Steinmetz and Sengelaub 1992) and US signals (Clark et al. 1997; Van Ham and Yeo 1992) , and also the IO, which discharges in response to the US (Gellman et al. 1983; Mostofi et al. 2010; Weiss et al. 1993) . The IO-cerebellar projections are somatotopically organized (Gellman et al. 1983; Weiss et al. 1993) , and the facial/eyelid components of the IO are regulated by a GABAergic feedback from the facial/eyelid components of the IN, forming so called olivo-cortico-nuclear modules (Pijpers et al. 2005) . A peculiar feature of IO physiology is that its neurons discharge at a very low spontaneous rate of 1-3 Hz (Gellman et al. 1983 ). Yet, blocking IO activity not only prevents the cerebellum from receiving the task-related US signals, but it also profoundly affects its functional state (Zbarska et al. 2007 (Zbarska et al. , 2008 . It is known that blocking the infrequent IO signals to the cerebellum eliminates cortical complex spikes, which are IO input-specific responses of Purkinje cells (Lang 2001 (Lang , 2002 Montarolo et al. 1982 ). This effect is, somewhat paradoxically, accompanied by a dramatic increase of Purkinje cell simple spiking (Colin et al. 1979; Montarolo et al. 1982) . Now, because Purkinje cells are GABAergic, their increased tonic activity inhibits neurons in their efferent target, the IN. Thus it is important to realize that attempts to manipulate IO sensory signals without controlling for possible changes in its spontaneous firing would inevitably affect the tonic state of cerebellar circuits, including the cerebellar output neurons in the IN Zbarska et al. 2007 Zbarska et al. , 2008 . In studies of IO signal function, IO manipulation-induced shifts in cerebellar tonic activity represent an undesirable side effect, which can completely obscure results. In the present study, we attempted to circumvent this problem by employing a simultaneous blockade of glutamate and GABAergic inputs to the IO.
Effects of DGG. Consistent with our previous reports (Zbarska et al. 2007) , blocking fast glutamate receptors in the DAO abolished previously acquired CRs. We presume that DGG blocked IO US signals and also significantly suppressed the spontaneous firing rate of IO neurons (Lang 2001 (Lang , 2002 . Since it is known that reducing IO activity dramatically elevates simple spike firing of cerebellar cortical Purkinje cells (Cerminara 2004; Montarolo et al. 1982; Rasmussen et al. 2008; Savio and Tempia 1985) and that increasing the activity of the GABAergic Purkinje cells further inhibits their efferent targets in deep cerebellar nuclei (Batini et al. 1985; Zbarska et al. 2007 Zbarska et al. , 2008 , it is likely that the suppression of IN activity was responsible for abolishing CRs (Fig. 6B ). Similar to our prior reports, the onset of the DGG effect was relatively fast, and unlike behavioral extinction, it has been shown to be independent of the application of paired CS/US trials (Zbarska et al. 2007 (Zbarska et al. , 2008 . These features of CR suppression further support the notion that the behavioral effects of DGG are best explained by the tonic inhibitory effect on IN neuronal activity. Similar CR abolition is typically observed when the activity of the IN is directly suppressed by a direct application of GABA A . Group effects of combined DGG-gabazine injections in the IO on CR incidence and baseline eyelid aperture. All data points represent group means Ϯ SE (n ϭ 5). A: effect of DGG followed by gabazine (ࡗ) or by aCSF (□) on CR incidence. After DGG, CRs were completely suppressed. Follow-up injections of gabazine at the same site accelerated the recovery of CRs. Double control injections of vehicle (OE) did not affect CR performance. B: effect of combined DGG-gabazine injections on baseline eyelid aperture. After gabazine, tonic baseline eyelid closure increased significantly during the 2nd half of postinjection trials while in control experiments it was not affected.
agonists (Aksenov et al. 2004; Bracha et al. 1994; Krupa and Thompson 1997) . Clearly, behavioral outcomes of inactivating the IO are functionally analogous to disconnecting the cerebellum (Horn et al. 2010; Welsh and Harvey 1998; Zbarska et al. 2007 Zbarska et al. , 2008 , and the resulting major behavioral effects make it impossible to assess the possible role of IO task-related signals.
Effects of gabazine. Injecting the potent GABA A antagonist gabazine in the DAO did not affect CR incidence. This confirms a previous report on the effects of the chloride channel blocker picrotoxin (Medina et al., 2002) . The main effects of gabazine were shortened CR latencies (Fig. 3B) and increased tonic eyelid closure, which was manifested as "squinting" of the ipsilateral eyelids between trials (Fig. 3C) . Pertinent to the likely neurophysiological mechanism of these effects, qualitatively similar eyeblink changes are known to follow injections of GABA A antagonists in the IN (Aksenov et al. 2004; Bracha et al. 2001; Garcia and Mauk 1998; Parker et al. 2009) . It is also known that reducing IO inhibition elevates IO spontaneous firing, and this translates into suppressed simple spike firing by cerebellar cortical Purkinje cells (Bengtsson et al. 2004; Lang 2002; Rawson and Tilokskulchai 1981) . Assuming that gabazine elevates the IO's firing rate, it is likely that the ensuing suppressed firing of Purkinje cells relaxed the inhibition of their target neurons in the IN (Fig. 6A ). This effect on the IN would be analogous to a direct pharmacological block of GABA A receptors in the IN and thus it is not surprising that eyeblink changes following IO GABA A antagonists are similar to the effects of GABA A antagonists applied to the IN.
Combined effects of DGG and gabazine. During combined injections of DGG and gabazine in the DAO, DGG first abolished CRs, and the follow-up infusion of gabazine led to a significantly accelerated CR recovery. Although we did not record cerebellar neuronal activity in this study, the pattern of behavioral results is consistent with the putative effects of these drugs on IO and cerebellar tonic firing rates (Fig. 7) . Specifically, we have reported elsewhere that DGG-induced CR abolition is accompanied by suppressed IN firing (Zbarska et al. 2007) , and that finding is further supported by Lang (2001) , who reported that injecting the IO with the glutamate antagonist 6-cyano-7-nitroquinoxalene-2,3-dione (CNQX) blocks IO responses to central stimulation and also suppresses IO spontaneous activity. Lang also found that follow-up injections of picrotoxin elevate the suppressed IO activity (Lang 2002) , which is an effect that most likely develops during our post-gabazine CR recovery. Since reducing inhibition of the IO has been shown to decrease Purkinje cell firing (Bengtsson et al. 2004) , we presume that this tonic effect was instrumental in the partial or perhaps even complete restoration of IN spontaneous activity and CR expression. Pertinent to this interpretation, disinhibiting the IO or the IN was previously shown to be supportive of CR expression in rabbits. Bao and Thompson (2002) found that CRs abolished by suppressing IN activity with muscimol could be restored by renewing the IN activity with the application of the chloride Fig. 7 . Idealized schematic of the IO inactivation/activation-induced tonic changes that affect cerebellar output and CR expression. A: gabazine (GZ)-induced effect on the IO and cerebellum tonic activity and on CR expression (adapted from Zbarska et al., 2007) . Injections of gabazine in the IO increase the firing rate of IO neurons (IO:FR), thereby increasing the incidence of complex spikes in Purkinje cells of the cerebellar cortex (PC:CS). Based on published accounts, we speculate that this produces a dramatic decrease of Purkinje cell's simple spike firing (PC:SS). Decreased firing of GABA-releasing Purkinje cells then dis-inhibits the activity of IN neurons (IN:FR), which results in the increase of the tonic drive to eyeblink premotoneurons and thus shortened CR latencies. B: injections of DGG in the IO suppress the firing rate of IO neurons. This decreases the incidence of complex spikes in Purkinje cells of the cerebellar cortex and produces a dramatic increase of Purkinje cell's simple spike firing. Increased firing of Purkinje cells then tonically inhibits the activity of IN neurons, which results in a decrease of the drive to eyeblink premotoneurons and thus CR abolition. Follow-up injections of vehicle do not alter the limited recovery toward the end of the DGG experiment. C: combined effects of sequential DGG and GZ injections on the IO and cerebellum's tonic activity and on CR expression. Injections of DGG induce the same changes as in B. Then, follow-up injections of GZ increase the firing rate of IO neurons. It is likely that this will reduce Purkinje cell's simple spike firing to a rate near the preinjection level. This in turn decreases the inhibition of IN neurons, increasing the excitatory drive to eyeblink premotoneurons and thus accelerating CR recovery. channel blocker picrotoxin (Bao et al. 2002) . Also, disinhibiting the IO activity with picrotoxin prevents extinction of eyeblink CRs (Medina et al. 2002) and injections of picrotoxin in the IN can restore extinguished CRs (Medina et al. 2001) . These data collectively demonstrate that testing the physiological role of the IO by blocking IO task-related signals is extremely sensitive to being confounded by the tonic malfunction of cerebellar eyeblink conditioning networks. Here we showed that the tonic side effects of blocking glutamate-mediated IO US signals are detrimental, but they could be counterbalanced by gabazine to a degree sufficient for CR restoration. Thus one could ask the most intriguing question: did our rabbits generate gabazine-recovered CRs in the absence of IO US signals?
The present study did not answer this question conclusively. The objective was to block glutamate-mediated IO US signals while minimizing tonic side effects of DGG on the cerebellar circuitry. Gabazine injections were effective in accelerating the CR recovery, indicating that this drug was successful in restoring the DGG-suppressed IO firing. However, it is not clear whether the initial recovered CRs were occurring under conditions where DGG was still completely blocking IO responses to the US. Comparing the DGG/gabazine results with those for the DGG/vehicle control indicates that the gabazine-induced recovery occurred at times when the effect of DGG remained sufficient to suppress CR expression. Because the post-DGG gabazine effect was not immediate, it is possible that gabazine could counterbalance the DGG effect on spontaneous activity only when the effect of DGG started to wear off. If this was the case, one cannot exclude that the emergence of gabazinerecovered CRs was associated with the beginning of the recovery of IO US responses. Alternatively, the difference in onset timing between the effects of gabazine and post-DGG gabazine could reflect the lag involved in gradually recovering neuronal activity in the IO and its efferent targets from the deeply downregulated state induced by DGG to one that may be near-normal or even slightly elevated. Details of this scenario will have to be addressed in future electrophysiological studies that will record US IO-mediated responses during DGG/gabazine injections in the IO.
In summary, our data confirmed that the effects of pharmacological manipulations of IO signals are most likely attributable to ensuing changes of the tonic state of cerebellar circuits ). Blocking glutamate neurotransmission in the IO suppressed the IO firing rate and the resulting downregulation of neuronal activity in the IN abolished CRs. On the other hand, blocking GABA A neurotransmission in the IO elevated its spontaneous firing leading to decreased inhibition in the IN and the associated facilitation of CRs and circuits that control resting eyelid position. The most important finding is that the undesirable tonic side effects of the individual antagonists could be at least partially counterbalanced by their combined application (Fig. 6C ). This new approach and its results open new routes for investigations of cerebellar taskrelated signals during eyeblink conditioning.
